Centogene N.V. (CNTGF)
OTCMKTS
· Delayed Price · Currency is USD
0.162
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
Centogene Market Cap
Centogene has a market cap or net worth of $4.69 million as of October 31, 2024. Its market cap has decreased by -83.96% in one year.
Market Cap
4.69M
Enterprise Value
72.38M
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since November 5, 2019, Centogene's market cap has increased from 3.22M to 4.69M, an increase of 45.77%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2024 | 4.69M | -85.96% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | 235.67M | 17.83% |
| Dec 31, 2019 | 200.00M | 6,111.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 19.55B |
| Telix Pharmaceuticals Limited | 4.61B |
| Elekta AB (publ) | 2.35B |
| Ryman Healthcare Limited | 2.04B |
| Verano Holdings Corp. | 1.17B |
| Vireo Growth Inc. | 95.99M |
| Medexus Pharmaceuticals Inc. | 45.17M |